Kistler-Tiffany Companies’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-60
Closed -$2K 816
2022
Q3
$2K Hold
60
﹤0.01% 721
2022
Q2
$3K Buy
+60
New +$2.61K ﹤0.01% 689

Other funds holding BME

Kistler-Tiffany Companies's BME Position: Q4 2022 in Review

Kistler-Tiffany Companies sold out of BlackRock Health Sciences Trust (BME) in Q4 2022, closing a stake of 60 shares — an estimated $2K sold.

Kistler-Tiffany Companies first reported a position in BME in Q2 2022 and held it in 2 quarters. The position peaked at $3K in Q2 2022. 73 funds tracked by Wall St. Rank hold BME as of Q4 2022.

  • Kistler-Tiffany Companies reported no remaining BlackRock Health Sciences Trust position as of Q4 2022 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 60 BlackRock Health Sciences Trust shares in Q4 2022, an estimated $2K.
  • Kistler-Tiffany Companies first reported a position in BlackRock Health Sciences Trust in Q2 2022 and held it in 2 quarters.
  • Kistler-Tiffany Companies's BlackRock Health Sciences Trust position peaked at $3K in Q2 2022.
  • 73 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2022.

Based on Kistler-Tiffany Companies's 13F filing for Q4 2022, filed 30 Jan 2023.